IBERE PHARMACEUTICALS's ticker is IBERWS and the CUSIP is G46843119. A total of 36 filers reported holding IBERE PHARMACEUTICALS in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $2,649 | -77.9% | 148,800 | 0.0% | 0.00% | – |
| Q3 2022 | $12,000 | 0.0% | 148,800 | 0.0% | 0.00% | – |
| Q2 2022 | $12,000 | -60.0% | 148,800 | 0.0% | 0.00% | – |
| Q1 2022 | $30,000 | -62.5% | 148,800 | 0.0% | 0.00% | -100.0% |
| Q4 2021 | $80,000 | -23.8% | 148,800 | -15.0% | 0.00% | 0.0% |
| Q3 2021 | $105,000 | -21.1% | 175,100 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $133,000 | – | 175,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lynwood Capital Management Inc. | 9,800 | $108,054 | 0.10% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |